Skip to main content

ParAllele Bioscience Recently Won $660K from Two NIH Grants

NEW YORK, Dec. 29 (GenomeWeb News) - ParAllele Bioscience has won around $660,000 through a pair of recent grants from the US National Institutes of Health, according to the NIH.

 

The grants, which the NIH said are effective as of Dec. 26, but that ParAllele had not previously disclosed, include:

  • $443,897 to develop a high-throughput genotyping technology; and
  • $214,190 to study variation scanning with mismatch repair detection.

 

A ParAllele spokesperson told GenomeWebNews today that the first of these grants is to develop "ultra-high-throughput" genotyping technology, though the NIH describes it as "high-throughoput."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.